The need for new options in PrEP that are cost-effective and efficacious is driving innovation in the field of nanotechnology.
Join Treatment Action Group and the HIV Prevention Justice Alliance for a webinar on July 11, 12:30 – 2 p.m. CT, that will explore different forms of stigma that continue to pose a significant barrier to accessing comprehensive HIV prevention services
This module covers the impact of stigma on transgender individuals in healthcare settings. The module also will equip attendees to effectively engage transgender individuals who seek care.
The Journal of the Association of Nurses in AIDS Care (JANAC) plans to publish a special issue on the topic of Mental Health & Substance Use Issues in HIV Infection in early 2017.
More than 1.2 million people in the United States are living with HIV — and one in eight of them don’t know they have the infection, according to the Department of Health and Human Services. In Phoenix, one hospital is trying to find those people, diagnose them — and get them into treatment.
The Department of State Health Services will host the 2016 Test Texas Coalition Summit on May 12-13, 2016 in Austin, Texas. The purpose of this meeting is to convene DSHS Routine HIV Screening contractors and key stakeholders to review and discuss current issues related to Routine HIV Screening program implementation and sustainability. Day one of … Continue reading Test Texas Summit
Anthony Fauci summarizes recent research on the timing of ART and the efficacy of PrEP for prevention in this New England Journal of Medicine article. He calls for the resources and political will to increase HIV testing and treatment globally. Learn More about ART Program
The U.S. Preventative Services Task Force (USPSTF) recently released a draft statement assigning a grade A recommendation to screening for human immunodeficiency virus (HIV) in the general population 15 to 65 years of age.
Over the past few decades, one of the most perplexing questions in global health is how to stop HIV.
There have been campaigns involving condoms, abstinence and even the circumcision of all men younger than 46. But one relatively new strategy, called treatment as prevention, is causing quite a buzz.
The U.S. Preventive Services Task Force (USPSTF) is poised to release recommendations on screening for human immunodeficiency virus (HIV) infection that will endorse the routine testing of adults and adolescents, a position first adopted by the Centers for Disease Control and Prevention (CDC) in 2006.
Of the more than 1 million people in the U.S. infected with HIV, nearly half are black men, women and children — even though blacks make up about 13 percent of the population.
In early 1981, when I was designated as surgeon general, I had never heard about AIDS. No one had heard about AIDS, and the handful of scientists who knew about immunodeficiency didn’t even know what to call it, much less what it really was. AIDS entered the consciousness of the public health service quietly, gradually, and without fanfare.